: $Actelis Networks(ASNS)$ 中概退潮,玩你们俩兄弟够了,神经病一样的庄,疯狂的手法查看全文
usbiostock2018-06-28 19:46
$Arsanis, Inc.(ASNS)$ 公司宣布ASN100预防金黄色葡萄球菌肺炎临床2期试验未能达到主要终点,公司将终止该药的研发。公司重点将放在ASN500,用于预防呼吸道合胞病毒感染。查看全文
美股医药Z博士2017-12-12 11:33
$Arsanis, Inc.(ASNS)$ 来推荐一只IPO不久的股票,喜欢短线的朋友可以关注。公司具有很多极具潜力的单抗抗生素药物,目前股价已跌破发行价。今日两大投行提高它的评级,并给出23的目标价,结果有意思的是股价居然-12%。是个不错的短线机会,第一个目标价16左右。查看全文
$Actelis Networks(ASNS)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-23-054857 Act: 34 Size: 1 MB 网页链接
$Actelis Networks(ASNS)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001213900-23-052321 Act: 33 Size: 93 KB 网页链接
$Actelis Networks(ASNS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001839 Act: 33 Size: 1 KB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, item 8.01 Accession Number: 0001213900-23-050993 Act: 34 Size: 197 KB 网页链接
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-050534 Size: 6 KB 网页链接
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-050538 Size: 6 KB 网页链接
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-050537 Size: 6 KB 网页链接
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-050533 Size: 6 KB 网页链接
$Actelis Networks(ASNS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-23-050535 Size: 6 KB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, item 8.01 Accession Number: 0001213900-23-050077 Act: 34 Size: 198 KB 网页链接